Purpose: To evaluate the ability of spin-lock imaging to detect the uptake of 3-omethyl-D-glucose (3oMG) in normal brain and brain tumors in animals.
Methods: Measurements of the longitudinal relaxation rate in the rotating frame (R 1q ) were made over a range of spin-lock powers in rat brains bearing 9L tumors. The dispersion of R 1q values was quantified by DR 1q , the difference of R 1q values acquired with low and high locking powers. The glucose analogue 3oMG was administered intravenously and the differences of DR 1q values (DR diff 1q ) before and as a function of time after administration were calculated to isolate the contribution of 3oMG to the dispersions, which at high fields primarily reflects chemical exchange effects. In addition, the ratio of image signals from low and high locking fields (the spin-lock ratio, SLR), which requires fewer acquisitions and varies directly with DR 1q , was computed as an alternative measure of the variation with locking power, and changes in SLR (SLR diff ) after 3oMG were evaluated.
Results: Both DR diff 1q and SLR diff in tumors increased rapidly after injection, whereas intact brain showed a gradual increase up to 1 h. The DR diff 1q and SLR diff were significantly different between tumors and contralateral normal tissues.
Conclusion: Spin-lock methods can be used to detect 3oMG in vivo after injection, and appropriate analyses of MRI signals allow tumors to be distinguished from normal brain.
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| I NT ROD UCTI ON
Most cancer cells have high glycolytic rates and enhanced uptake of glucose or its analogues (e.g., 2-deoxy-D-glucose [2DG] and 2-deoxy-fluoro-D-glucose), which provides the basis for imaging detection and assessment of tumors by microscopy or PET. 1 High-sensitivity imaging of the uptake and kinetics of administered glucose or its analogues may provide information on tumor metabolism and the levels of glucose transporters in tissues, and enhance the diagnosis of cancer. 3-o-methyl-D-glucose (3oMG) is a nontoxic glucose analogue that is taken up by cells through glucose transporters, but which is not metabolized and which, unlike 2-deoxy-fluoro-D-glucose, is not phosphorylated by hexokinase. 3-o-methyl-D-glucose is therefore a candidate contrast lagent for detection by MRI. Glucose and its analogues contain exchanging protons in hydroxyl groups. In MRI, by labeling the exchanging protons with selective RF irradiation for some time, an accumulated chemical exchange with the water causes a significant reduction in the water signal. By measuring this change in the water signal, the presence of the solute molecules can be indirectly detected with higher sensitivity than by direct measurement. Recently, CEST imaging, which applies a long, frequency-selective RF pulse to saturate specific solute protons prior to measurement of the water signal, has been used to detect glucose and its analogues after intravenous administration. [2] [3] [4] [5] [6] [7] [8] [9] [10] However, hydroxyl protons exchange very rapidly, and are in the fast exchange regime, so their CEST effects extend over a broad range and overlap with the water proton resonance. 11, 12 The detection and quantification of glucose or its analogues by CEST is therefore challenging. Spin-lock imaging is another technique that is also sensitive to chemical exchange effects, especially at high fields. 13 Recently, a few studies have applied spin-lock techniques to detect glucose and its analogues in vivo after intravenous injections, and their results suggest that spin-lock techniques can have better sensitivity than CEST for detecting chemical exchange effects in the fast exchange regime.
14-19 R 1q , the longitudinal relaxation rate in the rotating frame, can be measured by comparing signals at a fixed locking power but at different locking times, and is well estimated by linearly adding individual exchange contributions. 20 Glucose transport and uptake have been studied with glucose analogues by imaging. 2-deoxy-D-glucose has been detected by both CEST and spin-lock techniques in tumors, and is phosphorylated by hexokinase into 2DG-6-phosphate, which is then trapped in brain cells for many hours. 21 Thus, signals from 2DG may accumulate over time and be detected later than those of D-glucose. However, 2DG is toxic at high concentrations, which limits its clinical applications. 3-omethyl-D-glucose is a glucose analogue that also targets the glucose transporter, but is not metabolized, and should provide higher MR signals than those of D-glucose. In addition, 3oMG is generally considered to be nontoxic, 6, 17, 22 although detailed studies of its toxicity have not been reported. Although CEST has been applied to detect 3oMG in tumors in vivo, spinlocking techniques have not been evaluated for this purpose.
In this paper, we demonstrate the ability of spin-lock imaging to detect the uptake of 3oMG in tumor-bearing rat brains.
| M ETH ODS
2.1 | Spin-lock signal-based and R 1q -based contrasts A spin-lock sequence usually contains a preparation cluster followed by data acquisition. The acquired spin-lock signal (S) after the spin-lock preparation can be described by 
where f s , k sw , and Dx s are the fractional solute concentration, solute-water exchange rate, and solute resonance frequency offset from water, respectively; R 2,0 is the intrinsic transverse relaxation rate of water protons without any chemical exchange contribution; and f 1 is the Larmor frequency associated with the locking field.
After the administration of contrast agents in tissues, not only may the chemical exchange contributions from the agents (e.g., f s and k sw ) change, but non-exchange-related effects (e.g., changes in S 0 , R 2,0 ), which influence the signal and R 1q , may also change. A change in R 2,0 after agent administration may, for example, be the result of osmotic effects that cause shifts in water compartmentation. 16, 17 Previously, we have shown how judicious selection of locking powers and combinations of data acquired with different powers can isolate chemical exchange effects from nonchemical exchange-related effects. 20, 26, 27 This notion is based on the premise that the dominant exchange processes occur at rates whose effects may be reduced with locking fields in a range of moderate to relatively high values, giving rise to a dispersion of R 1q values for different f 1 . Here we define a simple R 1q -based contrast as
where low and high denote the relative values of f 1 used in the measurement. This metric quantifies the contributions primarily of exchange processes. To calculate the specific contributions to R 1q of an agent after administration in vivo, the resultant difference in DR 1q is obtained by subtracting DR 1q values before injection from those after injection. This separates the exchange effects of the agent from other endogenous exchanging pools in tissues. Equation 4 defines DR diff 1q as DR diff 1q 5DR 1q j after injection 2DR 1q j base line (4) Although explicit calculation of rates provides more complete information, more convenient measures of contrast effects can be obtained with shorter acquisition times and higher SNR by fixing SLT and comparing two spin-lock weighted images. We define the spin-lock ratio (SLR) and SLR diff in Equations 5 and 6 as follows:
Here, we used DR 1q and SLR to quantify the effects of 3oMG in samples, and DR diff 1q and SLR diff to quantify the effects of 3oMG after administration in vivo.
| Sample preparation
A series of 3oMG solutions were used to evaluate the dependence of DR 1q on solute concentration. Four samples were made with 10, 20, 30, and 40 mM 3OMG in 1 3 phosphate buffered saline buffer, and pH was titrated to 7.0 using NaOH/HCl. All chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
| Animal preparation
Five rats bearing 9L tumors were used in this study. Each rat was injected with 1 3 10 5 9L glioblastoma cells in the right brain hemisphere to induce tumors, and was then imaged after 2 to 3 weeks when the tumor reached appropriate size. All rats were immobilized and anesthetized with a 2%/98% isoflurane/oxygen mixture during imaging. Respiration was monitored to be stable, and a constant rectal temperature of 37 8C was maintained throughout the experiments using a warm-air feedback system (SA Instruments, Stony Brook, NY). The rat jugular vein was catheterized for intravenous injections. A volume of 1.5 g/kg 3oMG was injected into each rat in 1 to 2 minutes. All animal experiments were approved by the Animal Care and Usage Committee of Vanderbilt University.
| Magnetic resonance imaging
We used a spin-lock preparation cluster (90 x -s y /4-s -y /4-180 ys y /4-s -y /4-90 -x ) introduced in a recent patent, 28 which shows better performance than several other approaches to compensate for B 0 and B 1 field inhomogeneities. 29 Each RF pulse in the spin-lock preparation cluster is a hard pulse. Spin-lock signals were acquired with f 1 varying from 100 to 3162 Hz. Spin-locking times were 1, 250, 500, 750, and 1000 ms for samples or 1, 25, 50, 75, and 100 ms for animal experiments. For the studies of 3oMG injections, spin-lock signals were continuously acquired over 10-minute intervals before, during, and after injection. The total acquisition time was approximately 7 minutes to acquire data to derive each R 1q dispersion using 8 different locking fields, and approximately 100 seconds and 20 seconds to acquire spin-locking signals with 2 locking powers to calculate only DR 1q and SLR, respectively. Water longitudinal relaxation rate (R 1w ) and semisolid pool size ratio (PSR) were obtained using a selective inversion-recovery quantitative magnetization transfer method before injection. 30 Specifically, a 1-ms inversion hard pulse was applied to invert the free water pool, and the subsequent longitudinal recovery times were set to be 4, 5, 6, 8, 10, 12, 15, 20, 50, 200 , 500, 800, 1000, 2000, 4000, and 6000 ms. Spin-echo EPI was used for image readout followed by a saturation pulse train to shorten the total acquisition time as described previously. 31 A constant delay time of 3.5 seconds was set between the saturation pulse train and the next inversion pulse. All measurements on both samples and animals were performed on a Varian DirectDrive horizontal 9.4T magnet with a 38-mm Litz RF coil (Doty Scientific, Columbia, SC) at 37 8C. Spin-lock images on animals were acquired using single-shot spin-echo EPI sequences. All images were acquired with matrix size 5 64 3 64, FOV 5 30 3 30 mm, slice thickness 5 2 mm, and 1 acquisition. Spin-lock data on phantoms were acquired with FID acquisitions.
| Data analysis
R 1q values were calculated by fitting the signal variation with SLT to a 3-parameter mono-exponential decay function in MATLAB (The MathWorks, Natick, MA). The average of 3 measurements before injection was used as baseline. DR 1q and DR diff 1q were calculated by comparing values at low power (100 Hz) and high power (3162 Hz). The SLR and SLR diff were calculated by comparing values of signals acquired with SLT of 50 ms at low power (100 Hz) and high power (3162 Hz). These 2 powers were chosen to isolate and maximize chemical exchange contributions while avoiding off-resonance effects at low power and remaining well within the maximum rating of the RF coil and amplifiers. The DR 1q and DR diff 1q were obtained before and every 10 minutes after injecting 3oMG. The Df s , k sw , and DR 2,0 were obtained by fitting the R 1q dispersion difference 10 minutes after injection to Equation 2. Here, Df s represents the fractional solute concentration of the injected agent, and DR 2,0 represents the variation of R 2,0 as a result of the injected agent. Table 1 lists the starting points and boundaries of the fit of these 3 parameters. To increase SNR, the R 1q dispersion difference was obtained by averaging the data from 5 rats. The Dx s was set to 1.4 ppm (560 Hz at 9.4 T) in the fitting. Regions of interest in tumors were outlined from the PSR map with values less than a threshold of 7%. Regions of interest of contralateral normal tissue were chosen to mirror the tumor regions of interest. Student's t-tests were used to evaluate differences between results, which were considered to be statistically significant when P < .05. Figure 1 shows the results of the spin-lock experiments on 3oMG solutions. Note in Figure 1B ,C that both DR 1q and SLR are linearly proportional to the concentration, although the fitted lines do not cross 0 at concentration of 0 mM. Also note in Figure 1A that R 1q increases with locking power from 100 to 316 Hz, which may be caused by the transverse relaxation in the rotating frame (R 2q ) off-resonance effect introduced by inhomogeneities in the static main field (see simulations in Supporting Information Figure S1 ). 18 Figure 2A,B show the R 1q dispersions from rat brains before (blue line) and at 10 minutes after (red line) injecting 3oMG, from normal tissues and tumors, respectively. The R 1q dispersion acquired before injection was used as a baseline. We found that the R 1q values from both tumors and normal tissues acquired 10 minutes after injecting 3oMG increased compared with baseline values. Also note that R 1q increases with locking power from 100 to 562 Hz, similar to the sample data in Figure 1A , which is caused by R 2q effects. from normal tissues and tumors, respectively. The R 1q dispersion difference removes pre-injection, endogenous chemical exchange effects, and thus can isolate the contribution from only the injected agent. Note that the increase with locking power from 100 to 562 Hz in the R 1q dispersion difference curve is negligible, confirming that off-resonance effects have little influence on DR diff 1q . We also fitted the R 1q dispersion difference to Equation 2 (black dashed curve) to obtain the exchange parameters. Table 2 lists the fitting results. Figure 3A shows the mean time courses of DR 1q from rat brains. Figure 3B ,C shows the mean time courses of DR diff 1q with lock power of 100 Hz (named R 1q (100 Hz) difference) and with lock power of 3162 Hz (named R 1q (3162 Hz) difference), respectively. Note that the R 1q (100 Hz) difference in tumor is higher than that in normal tissues, but the R 1q (3162 Hz) difference in tumor is lower than in normal tissues, consistent with different degrees of dispersion. Figure 3D shows the mean time course of DR diff 1q from rat brains. It was found ( Figure 3D ) that DR diff 1q in tumors increases quickly after injection, whereas intact brain showed a more gradual increase up to 1 hour. Figure 3E shows the mean time course of SLR diff from rat brains, which is in agreement with DR diff 1q in Figure 3D . It was also found that there are significant differences of both DR 
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We applied spin-lock techniques to detect 3oMG in animal brains and tumors in vivo. 3-o-methyl-D-glucose increases DR 1q values by chemical exchange between hydroxyl and water protons, but the effect decreases at higher locking ), considering the 2.7-times higher dose of 3oMG used in the previous study. 17 The fitted Df s in tumors is approximately 2 times that in normal tissues, which indicates an enhanced uptake of 3oMG in tumors; the fitted k sw in tumors is approximately 70% of that in normal tissues, which may be the result of differences in pH. The fitted DR 2,0 in tumors and normal tissues is small, which suggests that changes in nonexchange effects caused by 3oMG administration is negligible. Based on Equation 2, R 1q at low lock powers may be dominated by chemical exchange effects, but R 1q at high lock powers may be dominated by nonexchange effects. This can be confirmed by the comparison between the R 1q values and the fitted R 2,0 values. The R 1q (100 Hz) differences from tumors and normal tissues at 10 minutes after injection in Figure 3B (0.67 and 0.44 s ). Non-exchange-related effects are relatively insensitive to lock power, 17 so that subtraction of 2 R 1q values acquired with a low and a high lock power can remove nonexchange-related contributions, while retaining most of the chemical exchange effect, depending on the rate of exchange compared with the locking frequency. The R 1q (100 Hz) difference in tumors is higher than that in normal tissues in Figure 3B , but the R 1q (3162 Hz) difference in tumors is lower than that in normal tissues in Figure 3C , consistent with the greater dispersion in tumors over this range. Therefore, the subtraction of 2 R 1q acquired with a low and a high lock power can enhance the contrast between tumors and normal tissues.
As shown in Figure 4 and parametric maps of other rats in Supporting Information Figures S2-S5 
| C ONCL US I ON
We show that spin-lock imaging can be applied to detect 3oMG in vivo as a potential contrast agent, which is taken up in a fashion similar to glucose.
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